CMT1A-BioStampNPoint2023: Charcot-Marie-Tooth disease type 1A accelerometry dataset from three wearable sensor study

The CMT1A-BioStampNPoint2023 dataset provides data from a wearable sensor accelerometry study conducted for studying gait, balance, and activity in 15 individuals with Charcot-Marie-Tooth disease Type 1A (CMT1A). In addition to individuals with CMT1A, the dataset also includes data for 15 controls that also went through the same in-clinic study protocol as the CMT1A participants with a substantial fraction (9) of the controls also participating in the in-home study protocol. For the CMT1A participants, data is provided for 15 participants for the baseline visit and associated home recording duration and, additionally, for a subset of 12 of these participants data is also provided for a 12-month longitudinal visit and associated home recording duration. For controls, no longitudinal data is provided as none was recorded. The data were acquired using lightweight MC 10 BioStamp NPoint sensors (MC 10 Inc, Lexington, MA), three of which were attached to each participant for gathering data over a roughly one day interval. For additional details, see the description in the "README.md" included with the dataset.